Equity Analysis /
United States of America

US : Aerie Pharmaceuticals, Inc. - AERI | Weekly Rx Metrics: New Glaucoma Share High but Franchise Still Tracking to Low End of Guide

    Michael Parolari
    Michael Parolari

    Research Associate

    Follow
    CGS-CIMB
    25 July 2022
    Published byCGS-CIMB